HUTCHMED (China) (HCM) Gains from Sales and Divestitures (2019 - 2024)
HUTCHMED (China) (HCM) reported Gains from Sales and Divestitures of $10000.0 for Q4 2024, down 88.37% year-over-year from $86000.0 in Q1 2024, and down 88.37% quarter-over-quarter from $86000.0 in Q4 2023.
HUTCHMED (China) (HCM) Gains from Sales and Divestitures (2019 - 2024) Analysis & Trends
HUTCHMED (China) (HCM) has 6 years of Gains from Sales and Divestitures data on file, last reported at $10000.0 in Q4 2024.
- Gains from Sales and Divestitures for Q4 2024 came in at $10000.0, down 88.37% year-over-year; the trailing twelve-month figure through Dec 2024 was $10000.0 (down 88.37% YoY), and the FY2024 annual result was $10000.0, down 88.37% from the prior year.
- Gains from Sales and Divestitures slipped to $10000.0 in Q4 2024 per HCM's latest filing, from $86000.0 in the prior quarter.
- Over five years, Gains from Sales and Divestitures peaked at $111000.0 in Q4 2022 and troughed at $10000.0 in Q4 2024.
- A 5-year average of $72400.0 and a median of $85000.0 in 2020 frame the typical range for Gains from Sales and Divestitures.
- The sharpest annual moves came in 2020 and 2024: Gains from Sales and Divestitures surged 400.0% in 2020, then plunged 88.37% in 2024.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $85000.0 in 2020, then fell by 17.65% to $70000.0 in 2021, then soared by 58.57% to $111000.0 in 2022, then retreated by 22.52% to $86000.0 in 2023, then sank by 88.37% to $10000.0 in 2024.
- Business Quant data shows HCM's Gains from Sales and Divestitures at $10000.0 in Q4 2024, $86000.0 in Q4 2023, and $111000.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | HUTCHMED (China) | 1.16 Bn | -306.90 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Dec 31, 2023 | 86,000.00 |
| Dec 31, 2022 | 111,000.00 |
| Dec 31, 2022 | 111,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Dec 31, 2021 | 70,000.00 |
| Dec 31, 2020 | 85,000.00 |
| Dec 31, 2020 | 85,000.00 |
| Dec 31, 2019 | 17,000.00 |
| Dec 31, 2019 | 17,000.00 |